Join Steritas as we discuss exciting new research using the GTI-MD in health economics outcomes research (HEOR) studies to unmask steroid-toxicity in large datasets.
This is a panel discussion with the team that developed the approach to quantifying steroid-toxicity in large datasets. The GTI-MD deployed in a HEOR study of a rare disease had the power of a Phase 3 trial studying 600+ patients, in a fraction of the time and cost.
Steroid-toxicity Insights Webinar Series panel:
- Glenn Phillips, PhD, Vice President, Health Economics & Outcomes Research, Argenx
- John Stone MD MPH, Professor of Medicine, Harvard Medical School and The Edward A. Fox Chair in Medicine, Massachusetts General Hospital
- Albert Whangbo, PhD, Principal ZS Associates